초록 ▼

Various embodiments are directed to transgenic plants, including transgenic tobacco plants and derivative seeds, genetically modified to impede the transport of Cadmium (Cd) from the root system to aerial portions of transgenic plants by reducing the expression levels of HMA-related transporters. Va

Various embodiments are directed to transgenic plants, including transgenic tobacco plants and derivative seeds, genetically modified to impede the transport of Cadmium (Cd) from the root system to aerial portions of transgenic plants by reducing the expression levels of HMA-related transporters. Various embodiments are directed to transgenic tobacco plants genetically modified to stably express a RNAi construct encoding RNAi polynucleotides that enable the degradation of endogenous NtHMA RNA variants. Reduced expression of NtHMA transporters in transgenic plants results in substantially reduced content of Cadmium (Cd) in the leaf lamina. Various consumable products that are substantially free or substantially reduced in Cd content can be produced by incorporating leaves derived from transgenic tobacco plants modified to reduce the expression of NtHMA transporters.

대표청구항 ▼

1. An isolated polynucleotide selected from the group consisting of: (i) a polynucleotide comprising a sequence having at least 90% sequence identity to SEQ ID NO: 1, and encoding a NtHMA transporter having P1B-type ATPase activity;(ii) a polynucleotide comprising a sequence having at least 90% sequ

1. An isolated polynucleotide selected from the group consisting of: (i) a polynucleotide comprising a sequence having at least 90% sequence identity to SEQ ID NO: 1, and encoding a NtHMA transporter having P1B-type ATPase activity;(ii) a polynucleotide comprising a sequence having at least 90% sequence identity to SEQ ID NO: 3, and encoding a NtHMA transporter having P1B-type ATPase activity;(iii) a polynucleotide comprising a sequence having at least 90% sequence identity to SEQ ID NO: 47, and encoding a NtHMA transporter having P1B-type ATPase activity;(iv) a polynucleotide comprising a sequence encoding a polypeptide having at least 90% sequence identity to SEQ ID NO:2, wherein the polypeptide is a NtHMA transporter having P1 B-type ATPase activity; and(v) a polynucleotide comprising a sequence encoding a polypeptide having at least 90% sequence identity to SEQ ID NO: 49, wherein the polypeptide is a NtHMA transporter having P1B-type ATPase activity. 2. An expression vector comprising the isolated polynucleotide of claim 1. 3. A transgenic plant made by a process comprising introducing the isolated polynucleotide of claim 1 into a plant. 4. A transgenic cell line made by a process comprising introducing the isolated polynucleotide of claim 1 into a cell line. 5. A consumable tobacco product comprising transgenic leaves harvested from the transgenic plant of claim 3. 6. An NtHMA RNAi construct capable of inhibiting the expression of an NtHMA messenger RNA to which it corresponds, the construct comprising: a first sequence having at least 90% sequence identity to SEQ ID NO:3 or 47; a second sequence; and a third sequence having a reverse complementary sequence of the first sequence, positioned in the same orientation as the first sequence, wherein the second sequence is positioned between the first sequence and the third sequence, and the second sequence is operably-linked to the first sequence and to the third sequence. 7. A transgenic plant comprising the RNAi of claim 6 having a reduced Cd level in at least a part of the plant compared to the part in a non-transgenic counterpart. 8. A consumable tobacco product comprising transgenic leaves harvested from the transgenic plant of claim 7. 9. The product of claim 8, wherein a % Cd reduction is a value of at least about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99%. 10. The product of claim 8, wherein the Cd content is a value ranging from about 0.01 to about 0.05 ppm, from about 0.01 to about 0.1 ppm, from about 0.01 to about 0.5 ppm, from about 0.01 to about 1.0 ppm, or from about 0.01 to about 5 ppm. 11. A method for reducing Cd levels in at least a part of a plant, comprising: reducing levels of an NtHMA mRNA in the plant by causing expression of the RNAi construct of claim 6. 12. The method of claim 11, wherein the RNAi construct comprises: a first sequence having at least 90% sequence identity to SEQ ID NO:3 or 47;a second sequence; anda third sequence having a reverse complementary sequence of the first sequence, positioned in the same orientation as the first sequence, wherein the second sequence is positioned between the first sequence and the third sequence, and the second sequence is operably-linked to the first sequence and to the third sequence. 13. The method of claim 11, wherein following expression of the RNAi construct, the part of the plant has a Cd content reduced by at least about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, or 99%. 14. The method of claim 11, wherein following expression of the RNAi construct, the part of the plant has a Cd content ranging from about 0.01 to about 0.05 ppm, from about 0.01 to about 0.1 ppm, from about 0.01 to about 0.5 ppm, from about 0.01 to about 1.0 ppm, or from about 0.01 to about 5 ppm.